John M. Fahrenholz

A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma

Jonathan Corren, William W. Busse, Eli O. Meltzer et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 294 citations

Medicine, Immunology, Pharmacology +12

Estrogen and progesterone decrease let-7f microRNA expression and increase IL-23/IL-23 receptor signaling and IL-17A production in patients with severe asthma

Dawn C. Newcomb, Jacqueline Cephus, Madison G. Boswell et al. · Journal of Allergy and Clinical Immunology · 2015 · 149 citations · Full text

Life Sciences, Endocrinology, Immunology +15

Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma

Kevin R. Murphy, Joshua Jacobs, Leif Bjermer et al. · The Journal of Allergy and Clinical Immunology In Practice · 2017 · 146 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial

Douglas B. Tzanetos, John M. Fahrenholz, Theresa A Scott et al. · Annals of Allergy Asthma & Immunology · 2011 · 28 citations

Medicine, Pharmacology, Pharmacotherapy +5

Safety of multiple aeroallergen rush immunotherapy using a modified schedule

Viviana M. Temiño, Pingsheng Wu, Janet Konig et al. · Allergy and Asthma Proceedings · 2013 · 27 citations

Life Sciences, Pharmacology, Pharmacotherapy +15